My laboratory has been funded by NIDA since 1992 (FIRST Award, 1992-1997; RO1, 1996-2000) to study the role of glutamate in behavioral sensitization to amphetamine. Sensitization is an animal model for the intensification of craving that underlies drug dependency in human addicts. Work supported by my FIRST Award demonstrated that glutamate transmission is required for the development of sensitization and that sensitized rats show dramatic alterations in glutamate neurotransmission. The goal of my R01 is to characterize such alterations and determine how drugs of abuse, which initially target the dopamine (DA) transporter, ultimately produce adaptations in glutamate systems. This is important because it is likely that glutamate mediates the plasticity that underlies the transition from drug experimentation to drug dependency. An understanding of glutamate's role in drug-induced neuroadaptations may lead to the development of pharmacotherapies for the costly and tragic epidemic of addiction. My R01 has the following Aims: 1) To characterize amphetamine's effects on glutamate transmission in the ventral tegmental area (VTA), where sensitization is initiated. 2) To characterize amphetamine's effects on glutamate transmission in the nucleus accumbens (NAc), where sensitization is expressed. 3) To determine if repeated amphetamine administration leads to persistent changes in basal glutamate levels or turnover in VTA or NAc. 4) To determine if amphetamine-induced changes in glutamate transmission in VTA and NAc reflect disinhibition of glutamate-containing projections originating in prefrontal cortex. 5) To characterize effects of repeated amphetamine administration on expression of AMPA and NMDA receptor subunits in these circuits, both at mRNA and protein levels. While studies supported by my R01 have already led to novel hypotheses for glutamate's role in sensitization, we have reached a point where continued progress will require new experimental approaches. I am applying for this K02 Award to obtain relief from administrative and teaching responsibilities that now consume over 60 percent of my time. Under the plan described herein, these responsibilities will be significantly reduced, enabling me to devote 80 percent effort to implementing new approaches and integrating them with my existing research plan. There are 4 specific directions in which I plan to expand our research capabilities: 1) Improving methods for quantifying receptor expression, which is essential for identifying the phenotype(s) of neurons that exhibit amphetamine-induced changes in glutamate receptor expression. 2) Developing primary cultures of NAc neurons as a model system to study dopamine/glutamate receptor interactions. 3) Investigating glutamate involvement in conditioned locomotion, so as to begin to address the crucial role of environmental stimuli in eliciting craving. 4) Developing electrochemical methods for in vivo monitoring of glutamate levels. I have consulted with internationally recognized experts in the development of these new directions, all of whom will continue to provide training and consultation during the period of this Award.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Development Award - Research (K02)
Project #
1K02DA000453-01
Application #
6038211
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Frankenheim, Jerry
Project Start
2000-03-01
Project End
2005-02-28
Budget Start
2000-03-01
Budget End
2001-02-28
Support Year
1
Fiscal Year
2000
Total Cost
$82,258
Indirect Cost
Name
Rosalind Franklin University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
069501252
City
North Chicago
State
IL
Country
United States
Zip Code
60064
Boudreau, Amy C; Milovanovic, Mike; Conrad, Kelly L et al. (2012) A protein cross-linking assay for measuring cell surface expression of glutamate receptor subunits in the rodent brain after in vivo treatments. Curr Protoc Neurosci Chapter 5:Unit 5.30.1-19
Li, Xuan; Wolf, Marina E (2011) Brain-derived neurotrophic factor rapidly increases AMPA receptor surface expression in rat nucleus accumbens. Eur J Neurosci 34:190-8
Ferrario, Carrie R; Loweth, Jessica A; Milovanovic, Mike et al. (2011) Distribution of AMPA receptor subunits and TARPs in synaptic and extrasynaptic membranes of the adult rat nucleus accumbens. Neurosci Lett 490:180-4
Reimers, Jeremy M; Milovanovic, Michael; Wolf, Marina E (2011) Quantitative analysis of AMPA receptor subunit composition in addiction-related brain regions. Brain Res 1367:223-33
Ferrario, Carrie R; Li, Xuan; Wolf, Marina E (2011) Effects of acute cocaine or dopamine receptor agonists on AMPA receptor distribution in the rat nucleus accumbens. Synapse 65:54-63
Ferrario, Carrie R; Loweth, Jessica A; Milovanovic, Mike et al. (2011) Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²?-permeable AMPA receptors during the incubation of cocaine craving. Neuropharmacology 61:1141-51
Ferrario, Carrie R; Li, Xuan; Wang, Xiaoting et al. (2010) The role of glutamate receptor redistribution in locomotor sensitization to cocaine. Neuropsychopharmacology 35:818-33
Wolf, Marina E (2010) Regulation of AMPA receptor trafficking in the nucleus accumbens by dopamine and cocaine. Neurotox Res 18:393-409
Conrad, K L; Ford, K; Marinelli, M et al. (2010) Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration. Neuroscience 169:182-94
Wolf, Marina E (2010) The Bermuda Triangle of cocaine-induced neuroadaptations. Trends Neurosci 33:391-8

Showing the most recent 10 out of 20 publications